Search research articles
Contact Us
Filters
Showing results (1441-1450 of 1,491) with videos related to
Page
of 150
Sort By:
Blood Cancer Journal
|
April 19, 2025
Risk of lymphoid malignancy associated with cancer predisposition genes
Nicholas J Boddicker, Raphael Mwangi, Dennis P Robinson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 4, 2024
Refining Diagnostic Subtypes of Peripheral T-Cell Lymphoma Using a Multiparameter Approach
Catalina Amador, Dennis D Weisenburger, Ana Gomez, et al.
Blood
|
June 5, 2014
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
Edgardo R Parrilla Castellar, Elaine S Jaffe, Jonathan W Said, et al.
Blood Cancer Journal
|
August 8, 2025
Subsets of follicular lymphoma 3B have divergent outcomes: results from the prospective multicenter MER and LEO cohorts
Patrizia Mondello, Brianna Negaard, Andrew L Feldman, et al.
Blood Advances
|
February 18, 2026
Patterns of Care and Clinical Outcomes in Systemic Peripheral T-cell Lymphoma: The LEO-MER Prospective Cohort Study
Jia Ruan, Zhengming Chen, Melissa C Larson, et al.
Journal of Medicinal Chemistry
|
May 30, 2003
Neuromuscular blocking activity and therapeutic potential of mixed-tetrahydroisoquinolinium halofumarates and halosuccinates in rhesus monkeys
Eric E Boros, Vicente Samano, John A Ray, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2018
Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials
Matthew J Maurer, Hervé Ghesquières, Brian K Link, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2015
Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
Hervé Ghesquieres, Susan L Slager, Fabrice Jardin, et al.
Blood
|
April 3, 2015
The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma
Rebecca L Boddicker, N Sertac Kip, Xiaoming Xing, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 19, 2023
Multiomic Analysis Identifies a High-Risk Metabolic and TME Depleted Signature that Predicts Early Clinical Failure in DLBCL
Kerstin Wenzl, Matt Stokes, Joseph P Novak, et al.
Page
of 150
Search research articles
Search
Showing results (1441-1450 of 1,491) with videos related to
Sort By:
Page
of 150
Blood Cancer Journal
|
April 19, 2025
Risk of lymphoid malignancy associated with cancer predisposition genes
Nicholas J Boddicker, Raphael Mwangi, Dennis P Robinson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 4, 2024
Refining Diagnostic Subtypes of Peripheral T-Cell Lymphoma Using a Multiparameter Approach
Catalina Amador, Dennis D Weisenburger, Ana Gomez, et al.
Blood
|
June 5, 2014
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
Edgardo R Parrilla Castellar, Elaine S Jaffe, Jonathan W Said, et al.
Blood Cancer Journal
|
August 8, 2025
Subsets of follicular lymphoma 3B have divergent outcomes: results from the prospective multicenter MER and LEO cohorts
Patrizia Mondello, Brianna Negaard, Andrew L Feldman, et al.
Blood Advances
|
February 18, 2026
Patterns of Care and Clinical Outcomes in Systemic Peripheral T-cell Lymphoma: The LEO-MER Prospective Cohort Study
Jia Ruan, Zhengming Chen, Melissa C Larson, et al.
Journal of Medicinal Chemistry
|
May 30, 2003
Neuromuscular blocking activity and therapeutic potential of mixed-tetrahydroisoquinolinium halofumarates and halosuccinates in rhesus monkeys
Eric E Boros, Vicente Samano, John A Ray, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2018
Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials
Matthew J Maurer, Hervé Ghesquières, Brian K Link, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2015
Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
Hervé Ghesquieres, Susan L Slager, Fabrice Jardin, et al.
Blood
|
April 3, 2015
The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma
Rebecca L Boddicker, N Sertac Kip, Xiaoming Xing, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 19, 2023
Multiomic Analysis Identifies a High-Risk Metabolic and TME Depleted Signature that Predicts Early Clinical Failure in DLBCL
Kerstin Wenzl, Matt Stokes, Joseph P Novak, et al.
Page
of 150